[1] Niu Z, Hu H, Tang F.High free fatty acid levels are associated with stroke recurrence and poor functional outcome in chinese patients with ischemic stroke[J]. J Nutr Health Aging, 2017, 21(10): 1102-1106. [2] 国家卫生计生委防治工程委员会.中国卒中流行报告2015[M]. 北京:中国协和医科大学出版社,2015. [3] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2019[J].中华神经科杂志,2019,43(2): 146-152. [4] 蔡雪蓉,张学亚,潘敬新.纤溶酶原激活物抑制剂-1的研究进展[J].临床与病理杂志,2020,40(2):458-463. [5] Chen H, Nie S, Lu M, et al.Association between plasminogen activator in hibitor-1 gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis[J]. Am J Reprod Immunol, 2015, 73(4): 292-300. [6] 茅新蕾,韩丽雅,黄向东,等.纤溶酶原激活物抑制物-1基因4G/5G位点多态性与脑梗死的相关性研究[J].现代实用医学,2016,28(8):988-1008. [7] Akhter MS, Biswas A, Abdullah SM, et al.The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population[J]. Clin Appl Thromb Hemost, 2017, 23(8): 1071-1076. [8] Xu B, Kong X, Xu R, et al.Homocysteine and all-cause mortality in hypertensive adults without pre-existing cardiovascular conditions: Effect modification by MTHFR C677T polymorphism[J]. Medicine, 2017, 96(8): 1-8. [9] Li PP, Qin C.Methylenetetrahy drofolate reductase(MTHFR) gene polymorphisms and susceptibility to ischemic stroke: A meta-analysis[J]. Stroke Cerebrovasc Dis, 2016, 25(3): 679-687. [10] Li AF, Shi YS, Xu LY, et al.A possible synergistic effect of MTHFR C677T polymorphism on homocysteine level variations increased risk for ischemic stroke[J]. Medicine, 2017, 96(51): e9300. [11] 张金辉,冯曜宇,金辉.静脉血栓栓塞患者携带LeidenV因子杂合子病例报告[J].中国血管外科杂志(电子版),2014,6(3):170-174. |